Alpha Lipoic Acid (Liver Support) — Frequently Asked Questions
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Frequently Asked Questions
What is the difference between R-ALA and regular alpha lipoic acid?
What is the difference between R-ALA and regular alpha lipoic acid?
Regular ALA supplements contain a 50/50 racemic mixture of R-ALA (the naturally occurring, biologically active form) and S-ALA (a synthetic mirror image with lower biological activity). R-ALA is approximately twice as potent per milligram and is better absorbed. A 300mg dose of R-ALA is roughly equivalent to 600mg of racemic ALA. R-ALA is more expensive but more effective per dose.
Can alpha lipoic acid help with fatty liver disease?
Can alpha lipoic acid help with fatty liver disease?
Yes, ALA addresses multiple NAFLD mechanisms: it improves insulin sensitivity (a primary NAFLD driver), recycles glutathione (depleted in fatty liver), reduces oxidative stress in hepatocytes, and may promote weight loss. Clinical studies using 600-1200mg/day ALA show reduced ALT and improved liver imaging. ALA is best combined with diet and exercise modifications for NAFLD management.
Should I take ALA on an empty stomach?
Should I take ALA on an empty stomach?
Yes, ALA absorption is significantly reduced by food — studies show up to 30-40% lower blood levels when taken with meals. Take ALA 30 minutes before eating for optimal absorption. If stomach upset occurs on an empty stomach, taking it with a small amount of food is an acceptable compromise, though absorption will be somewhat reduced.
References
- Packer L, Witt EH, Tritschler HJ (1995). Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine. DOI PubMed
- Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ, Lee IK, Lim S, Jang HC, Lee KH, Lee KU (2011). Effects of alpha-lipoic acid on body weight in obese subjects. American Journal of Medicine. DOI PubMed
- Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K (1999). Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radical Biology and Medicine. DOI PubMed
- Patrick L (2002). Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Alternative Medicine Review. PubMed